STRATA Skin Sciences, Inc. (SSKN)
NASDAQ: SSKN · IEX Real-Time Price · USD
3.630
+0.070 (1.97%)
At close: Jul 19, 2024, 4:00 PM
3.510
-0.120 (-3.31%)
Pre-market: Jul 22, 2024, 7:29 AM EDT
STRATA Skin Sciences Revenue
STRATA Skin Sciences had revenue of $32.55M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $6.75M. In the year 2023, STRATA Skin Sciences had annual revenue of $33.36M.
Revenue (ttm)
$32.55M
Revenue Growth
-11.29%
P/S Ratio
0.39
Revenue / Employee
$328,737
Employees
99
Market Cap
12.73M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 33.36M | -2.80M | -7.75% |
Dec 31, 2022 | 36.16M | 6.18M | 20.63% |
Dec 31, 2021 | 29.98M | 6.89M | 29.83% |
Dec 31, 2020 | 23.09M | -8.50M | -26.90% |
Dec 31, 2019 | 31.59M | 1.73M | 5.80% |
Dec 31, 2018 | 29.86M | -1.91M | -6.01% |
Dec 31, 2017 | 31.76M | 1.06M | 3.44% |
Dec 31, 2016 | 30.71M | 12.21M | 66.03% |
Dec 31, 2015 | 18.50M | 17.58M | 1,921.31% |
Dec 31, 2014 | 915.00K | 379.00K | 70.71% |
Dec 31, 2013 | 536.00K | 258.00K | 92.81% |
Dec 31, 2012 | 278.00K | - | - |
Dec 31, 2011 | 0 | - | - |
Dec 31, 2010 | 0 | - | - |
Dec 31, 2009 | 0 | - | - |
Dec 31, 2008 | 0 | - | - |
Dec 31, 2007 | 0 | - | - |
Dec 31, 2006 | 0 | - | - |
Dec 31, 2005 | 0 | - | - |
Dec 31, 2004 | 0 | - | - |
Dec 31, 2003 | 0 | - | - |
Dec 31, 2002 | 547.29K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Novo Integrated Sciences | 13.52M |
Ontrak | 12.89M |
Guardion Health Sciences | 12.06M |
NEXGEL | 4.74M |
Addex Therapeutics | 1.57M |
SSKN News
- 6 weeks ago - STRATA Skin Sciences' TheraClear®X Acne Therapy System Found to be Safe and Effective for Acne Lesions Across All Fitzpatrick Skin Types with Favorable Tolerability and Patient Satisfaction as Published in Peer Reviewed Journal - GlobeNewsWire
- 6 weeks ago - STRATA Skin Sciences to Participate in June Dermatology Conferences - GlobeNewsWire
- 2 months ago - STRATA Skin Sciences Reports First Quarter 2024 Financial Results and Provides a Corporate Update - GlobeNewsWire
- 2 months ago - STRATA Skin Sciences Surpasses 100 Domestic Installations of TheraClear®X Devices as of March 31, 2024 - GlobeNewsWire
- 2 months ago - STRATA Skin Sciences to Participate in the Benchmark Healthcare House Call Virtual 1x1 Investor Conference - GlobeNewsWire
- 2 months ago - STRATA Skin Sciences to Report First Quarter 2024 Financial Results on May 15, 2024 and Provide Corporate Update - GlobeNewsWire
- 2 months ago - STRATA Skin Sciences Announces XTRAC® Comeback Placements in the First Quarter of 2024 - GlobeNewsWire
- 3 months ago - STRATA Skin Sciences Announces 1-for-10 Reverse Stock Split - GlobeNewsWire